FDA Approvals

Date Posted
Article Title
5/10/2013
Breo Ellipta Approved for COPD

Respiratory disease is the third-leading cause of death in U.S.

5/1/2013
4/30/2013
4/9/2013
Diclegis Approved for Morning Sickness

Among pregnant women who haven't responded to other treatments

4/1/2013
New Drug Approved for Type 2 Diabetes

Invokana blocks reabsorption of glucose by the kidneys

3/28/2013
3/25/2013
Inhaler Approved for Cystic Fibrosis Patients

Antibiotic device treats Pseudomonas aeruginosa lung infections

3/21/2013
Dotarem Approved for Nervous System MRIs

Contrast agent helps doctors view brain and spine

3/13/2013
Lymphoseek Approved to Help Locate Lymph Nodes

Among people with certain cancers

2/14/2013
2/8/2013
Pomalyst Approved for Advanced Multiple Myeloma

After other therapies have failed

2/4/2013
First Generic Version of Cancer Drug Doxil Approved

Brand-name drug is in short supply, agency noted

2/1/2013
Ravicti Approved for Urea Cycle Disorders

Conditions inhibit ammonia removal from the body

1/30/2013
Drug OK'd for Deadly Genetic Condition Tied to Cholesterol

Kynamro can be used when the body can't eliminate 'bad' cholesterol, FDA says

1/28/2013
Three New Drugs Approved for Type 2 Diabetes

All contain new active ingredient aimed at improving glucose control

1/25/2013
Gleevec's Latest Approval is for Pediatric Cancer

Drug blocks proteins that fuel cancer-cell development

1/25/2013
1st OTC Drug Approved for Women With Overactive Bladder

Oxytrol is intended for use by those 18 and older

1/23/2013
Drug Approved for Inherited Blood Disorder

Exjade removes excess iron, FDA says

1/22/2013
Botox Approved for Overactive Bladder

When people don't respond to standard treatments

1/17/2013
Octaplas Approved for Blood-Clotting Disorders

Made from treated human plasma